(TSX:TECK.A),(TSX:TECK.B),(TSX:TECK-A),(TSX:TECK-B),(NYSE:TECK), VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) will release its second quarter 2025 earnings results before market open on Thursday, July 24, 2025. A webcast to review the results will be held as follows: Date: Thursday, July 24, 2025 Time: 8:00 a.m. […]
DALLAS, July 08, 2025 (GLOBE NEWSWIRE) — Visionary real estate entrepreneur and community advocate Bill Hutchinson has made a generous philanthropic contribution to St. Philip's School and Community Center, furthering his commitment to empowering underserved communities through education, service, and strategic investment in Dallas's future. The donation supports St. Philip's unwavering mission to provide an
Teck to Release Second Quarter 2025 Results on July 24, 2025 GlobeNewswire July 08, 2025 VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) will release its second quarter 2025 earnings results before market open on Thursday, July 24, 2025. A webcast to review the
Bill Hutchinson Strengthens Educational Access with Transformative Gift to St. Philip's School and Community Center GlobeNewswire July 08, 2025 DALLAS, July 08, 2025 (GLOBE NEWSWIRE) — Visionary real estate entrepreneur and community advocate Bill Hutchinson has made a generous philanthropic contribution to St. Philip's School and Community Center, furthering his commitment to empowering underserved communities
(CNSX:RVV.CN),(CNSX:RVV),(OTC US:RVVTF),(Other OTC:RVVTF),(Frankfurt:31R), TORONTO, July 08, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases and medical countermeasures, hereby clarifies its update regarding the research study assessing Bucillamine as a potential treatment
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study GlobeNewswire July 08, 2025 TORONTO, July 08, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases and medical countermeasures, hereby clarifies its
(TSE:6963.T), Santa Clara, CA and Kyoto, Japan, July 08, 2025 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced the development of the AW2K21, a 30V N-channel MOSFET in a common-source configuration that delivers an industry-leading ON-resistance of just 2.0mΩ (typ.) in a compact 2.0mm × 2.0mm package. With the rise of compact devices featuring large-capacity batteries,
ROHM Develops an Ultra-Compact MOSFET Featuring Industry-Leading* Low ON-Resistance Ideal for Fast Charging Applications GlobeNewswire July 08, 2025 Santa Clara, CA and Kyoto, Japan, July 08, 2025 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced the development of the AW2K21, a 30V N-channel MOSFET in a common-source configuration that delivers an industry-leading ON-resistance of just 2.0mΩ
Spin Master Corp. (“Spin Master”) (TSX: TOY), a leading global children's entertainment company, will report its second quarter 2025 financial results on Thursday, July 31, 2025, at approximately 6:30 a.m. (EDT). Q2 2025 Conference Call Christina Miller, Chief Executive Officer andJonathan Roiter, Executive Vice President & Chief Financial Officer, will host a conference call for
Vistra (NYSE: VST) plans to report its second quarter 2025 financial and operating results on Thursday, Aug. 7, 2025, during a live conference call and webcast beginning at 9 a.m. ET (8 a.m. CT). https://mma.prnewswire.com/media/1393749/Vistra_Corp_Logo.jpg The live webcast can be accessed via Vistra's website at www.vistracorp.com under “Investor Relations” and then “Events & Presentations.” Participants